IE 11 is a very old browser and is not supported on this site.


About us

Sustainability is an integral part of Galenica’s corporate management. This is based on the steadfast belief that proactive and responsible action contributes significantly to the long-term economic success of a company and has an impact both within and outside a company.

Our sustainability principles

We firmly believe that our Group can achieve long-term commercial success only if we also bear responsibility for society and use natural resources sparingly and efficiently.

This conviction is reflected in the three key sustainability principles of Galenica, in addition to our customer promise. Supported by the Executive Committee, they form an essential part of the Group’s corporate culture.

Company value

We increase the value of the company in the long term by having a sustainable impact.


We oblige our employees to act responsibly and ensure they have a safe, flexible and supportive working environment.

Resource efficiency

We use resources sparingly and efficiently and reduce negative environmental impacts.

With these guiding principles, we educate and motivate employees to continuously increase our resource intensity, efficiency, capacity for innovation and, ultimately, competitiveness. On the other hand, the lively, ongoing dialogue with the various stakeholders helps to identify requirements and expectations at an early stage and to maintain Galenica’s strong reputation.

Our key sustainability topics are integrated into the corporate vision and the objectives of the strategic programmes and are therefore part of the corporate strategy.

Sustainability organisation (GRI 2-12, 2-13, 2-17)

The Board of Directors bears ultimate responsibility for the economic, environmental and social impact of the Galenica Group. The Governance, Nomination and Sustainability Committee (GNSC) advises the Chair of the Board of Directors and the entire Board of Directors on sustainability matters. The Committee consists of the Chair of the Board of Directors, the Vice Chair and other members who are elected by the Board of Directors on the proposal of the Chair of the Board of Directors. Among other things, the Committee reviews the relevance matrix and the sustainability goals on an annual basis and ensures that the corporate strategy is geared towards sustainable management. In the reporting year, the GNSC discussed the topic of sustainability twice. The Board of Directors approves the sustainability goals and monitors progress in achieving them. The topic of sustainability was discussed by the Board of Directors four times in 2023. The Executive Committee is responsible for implementing the sustainability goals and integrating sustainability into day-to-day business.

The Sustainability Committee (SC) is led by the Chief Transformation Officer and plays an advisory and coordinating role. The Committee develops specific proposals for implementing the sustainability strategy for the attention of the Executive Committee and the Board of Directors. The main task is to systematise internal sustainability management and external reporting and to ensure that the measures are implemented. The Committee is structured in such a way that, in addition to be able to cover all key sustainability topics, all Business and Service Units and the Executive Committee are also represented on the Committee by a responsible person.

The SC met four times in the reporting year. In between Committee meetings, several smaller meetings were held by individual working groups to discuss the progress made with the sustainability goals and the implementation of the measures. In 2023, the measures were further specified or already implemented. This is mainly done in the Business Units. The SC coordinates the activities and the Chief Transformation Officer regularly reports to the Executive Committee and the Board of Directors.

Sustainability organisation

Materiality matrix (GRI 2-14, 3-1, 3-2)

In 2023, Galenica conducted a materiality analysis based on the dual materiality principle. First, the impact of Galenica’s business activities on the social, environmental and economic environment was assessed through interviews with experts and stakeholders relevant to Galenica. We also drew on legal requirements, information from ESG standards and ratings, and peer comparisons to determine the impact. The identified impacts of business activities were summarised into overarching topics and discussed by the Executive Committee and the Board of Directors. Using an online survey, internal and external stakeholders – investors, partners, suppliers, customers, associations, employees and authorities – were asked about the key topics. They had to assess each from two perspectives and assign a score from very low to very high:

  • Relevance for Galenica (outside-in perspective)
  • Relevance for the social, environmental and economic environment of Galenica (inside-out perspective)

We have evaluated the results of the online survey and summarised them in the matrix below. The materiality matrix was acknowledged by the Executive Committee and the Board of Directors.

Further information on managing the material topics can be found in the section Sustainability organisation.

Galenica provides information on the development of material topics once a year in its sustainability report. The Board of Directors is responsible for reviewing and approving the reported information.

Our sustainability goals

The SC has defined specific targets for all material sustainability topics, which were approved by the Executive Committee and the Board of Directors at the end of 2021. In 2023, the SC adjusted some of the goals. This was approved by the Executive Committee and the Board of Directors at the end of 2023.

Corporate governance

We train all employees in compliance at least once a year.

Twice a year, we carry out measures to raise employee awareness in the area of data protection.

We make our employees aware of IT security and cybercrime.

Patients and customers

We will increase the use of Clinical Decision Support Checks (CDS.CE) to 500 million by 2025 and 1 billion by 2030.

Starting in 2025, our top 10 suppliers are to be audited every three years for compliance with the Supplier Code of Conduct.

Customer satisfaction is at the heart of everything we do. NPS is used to systematically measure the satisfaction of end customers and determine the gap compared to the average of the competition.

We are increasing the number of healthcare services provided by 10% annually until 2027.


We will increase the motivation rate of our employee survey to 75 out of 100 points and the participation rate to 75% by 2024.

We will reduce the time-to-hire for IT and pharmacist positions by 10% by 2024 and reduce the Group-wide fluctuation by 6%.

We will improve diversity in all Service Units and keep the proportion of female managers at 50%.

We will reduce the number of cases due to mental illness.

We will reduce the absence rate of occupational and non-occupational accidents by 10% by 2024.


From 2025, we will be sourcing 100% of our electricity from renewable sources at all our locations.

We will reduce the greenhouse gas emissions produced by all our operations, processes and supply chains by 25% by 2025 and by 50% by 2030.

We will replace 40% of the fossil fuels in our vehicle fleet with renewable alternatives by 2028.

We will reduce our municipal waste by 50% by 2025.

The target for the time to hire with regard to retaining qualified employees has been adjusted as well as the additional parameter fluctuation, as the overriding objective of retaining qualified employees cannot be achieved simply by reducing the time to hire. The new objective is as follows: We will reduce the time to hire for pharmacy staff and IT (difficult hires) by 10% by 2024 and Group fluctuation by 6%.

In the 2023 materiality process, health promotion was also identified as a new relevant topic and positioned in the relevance matrix. A new objective has also been defined for this new topic: We will increase the number of healthcare services provided by 10% annually until 2027. In addition, a new NPS target was defined on the topic of customer satisfaction: Customer satisfaction is at the heart of everything we do. NPS is used to systematically measure the satisfaction of end customers and determine the gap compared to the average of the competition.

With the measures taken and implemented in 2023, achievement of the targets is generally realistic and on track. A few targets have been delayed slightly due to new or adapted processes and expanded data bases. Only the target “We train all employees in compliance at least once a year” was rated as critical at the end of 2023, as a quota of 100% is hardly achievable due to holiday absences or illness.

Progress towards our sustainability goals can be found in the GRI report.

Dialogue with stakeholders (GRI 2-29)

Galenica maintains relationships with its stakeholders that are characterised by transparency, honesty and mutual trust. Galenica’s stakeholders include individuals, interest groups and organisations who directly or indirectly influence or are affected by the company's values, actions and performance.

A meaningful stakeholder engagement is characterised by continuous two-way communication and depends on the goodwill of all those involved. Galenica strives for successful collaboration by promoting regular exchange through various communication channels. This allows the various stakeholder groups to proactively voice their concerns and expectations of the company at any time. Galenica is addressing the issues arising from this and shaping further dialogue in accordance with the current challenges and needs of its stakeholders. This ensures that the topics are relevant to stakeholders and that the dialogue brings added value for both sides. The Executive Committee regularly discusses the concerns and priorities of the various stakeholder groups and reports to the Board of Directors. In this way, stakeholder concerns are incorporated into the decision-making process as far as possible.

Stakeholder group

Why we are committed

How we are committed

Topics discussed in 2023


Increase customer satisfaction

Customer surveys

Satisfaction with healthcare services

Determine potential for improvement


Low-threshold access to healthcare services


Increase trust in the company

Dialogue at AGM

Galenica’s role in Swiss healthcare


Annual communication via AR

Further development of the company

Galenica as an attractive and secure investment

IR Day and roadshows

Innovation and new business areas


Direct investor dialogue



Continuous improvement process in quality management

Code of Conduct for Suppliers

Quality aspects


Direct dialogue between Purchasing and delivery partners

Costs and prices

Providing a seamless service

Satisfaction survey of key suppliers


Supply chain integrity

Safety Stock initiative

Supply chain integrity

Ensuring ability to deliver


Product availability

Scientific institutions

Promoting young talent

Financing of the Chair of the University of Bern (Pharmacy)

Quality of teaching

Training for healthcare professions

Lectures on vocational training

Attractiveness of healthcare professions (retail pharmacy)

Current and potential employees

Attracting and retaining qualified employees

Active recruitment

Galenica as an attractive employer

Employee satisfaction and motivation

Fringe benefits

Attractiveness of healthcare professions


Fair employment conditions



University marketing / events



Position Galenica as an employer of choice


Authorities and associations

Political influence

Membership of association boards

Galenica’s role in Swiss healthcare

Ensuring sustainable business operations

Regular dialogue with relevant associations

Opportunities and risks of liberalisation in the healthcare sector


Meetings with politicians, authorities

Costs / cost containment

Protecting its stakeholders is a top priority for Galenica. The company complies with the applicable laws and regulations, specifically in the areas of data protection, occupational health and safety, investor protection, environmental protection and consumer protection. Suspicions of non-compliance with laws and regulations can be reported via the external whistleblower reporting office. Details can be found in the section Sustainable and ethical corporate governance.

Galenica employees have access to other points of contact. The MOVIS social counselling service supports them with issues relating to health and work-life balance, and individual case management ensures appropriate work arrangements for people with health issues or mental disabilities.

Galenica ensures that its customers are protected by providing patient-oriented advice in pharmacies and in the home care sector. Advice is individually tailored to the needs of patients and takes into account the latest medical findings. More information can be found in the chapters on Patient safety and Health promotion.

Memberships of associations and interest groups
(GRI 2-28)

Galenica is involved in various healthcare and industry associations in order to represent its interests. Membership in these organisations allows us to help shape the framework conditions for Galenica and strengthen our network. In addition, we gain new insights into our business activities through exchanges with other companies and organisations. In the reporting period, Galenica was a member of the following associations and interest groups:

ASSGP, Association of the Swiss Self-Medication Industry
GESKES, Society for Clinical Nutrition in Switzerland
GSASA, Swiss Association of Public Health Administration and Hospital Pharmacists
Helvecura Genossenschaft, compulsory storage organisation for therapeutic products
Refdata, Refdata Foundation
Avenir Suisse Trägerverein, Swiss Umbrella Association of Physician Networks
pharmalog, Swiss Pharma Logistics Association
pharmaSuisse, Swiss Association of Pharmacists
ScienceIndustries, Business Association for Chemistry-Pharma-Biotech
Swiss Medtech, Swiss Medical Technology Association
GFH Healthcare Retailers Association
VIPS, Association of Pharmaceutical Companies in Switzerland
VSVA, Association of Swiss Mail-order Pharmacies
Association QualiCCare, Association for the Improvement of Quality in Treatment of Chronic Diseases in Switzerland
ASTAG, Swiss Commercial Vehicle
Association Freedom Healthcare Alliance
GIRP, European Healthcare Distribution Association
HIV, Trade and Industry Association of the canton of Bern
eHealth Interest Group
SGGP, Swiss. Society for Health Policy
SMVO, Swiss Medicine Verification Organisation
SVKH, Swiss Association for Therapeutic Products in Complementary Medicine
Association of Industrial and Service Groups in Switzerland
VNL Schweiz, Verein Netzwerk Logistik e.V., Logistics Network Association

Our contribution to the Sustainable Development Goals

The Sustainable Development Goals (SDGs) form the global reference framework for sustainable development. The Galenica Group is committed to the SDGs. As Switzerland’s leading fully integrated healthcare provider, we make an important contribution to SDG 3 (Health and Well-being). This objective is central to our business activities and is in line with our customer promise to support people at every stage of life on their journey towards health and well-being. We also contribute to SDG 8 (Decent Work and Economic Growth), SDG 12 (Responsible Consumption and Production), SDG 13 (Climate Action), SDG 10 (Reduced Inequalities) and SDG 16 (Peace, Justice and Strong Institutions) through our corporate activities.


Patient safety and health

Patient safety and health are a top priority for us. With personal and competent advice and a unique range of products and services, we support our patients in all life situations at every stage of their lives, promote their well-being and enable people of all ages to lead a healthy life.


Emissions and climate change

We promote the use of renewable energies in distribution and the use of public transport and electromobility by our employees. We always take measures to increase energy efficiency into account and examine the feasibility of installing photovoltaic systems. In addition, we have defined specific targets for reducing greenhouse gas emissions, replacing fossil fuels and using exclusively renewable energy sources at all operation sites. We also rely on supply chain partnerships in accordance with SDG 17 to promote recycling with regard to the climate, water and waste. With these measures, we are contributing to the fight against climate change.


Waste and recycling

In addition to traditional municipal waste, we also produce medical and chemical waste. The prevention, reduction, recycling and professional disposal of waste is of central importance to us. We also contribute to biodiversity conservation by disposing of medications properly. Environmentally friendly waste management forms the basis for responsible consumption and production.


IT security and cybercrime

With the increasing digitalisation of the healthcare system, the risk of cyber attacks is growing. This is why IT security is highly important at Galenica. As a healthcare provider, we process sensitive information and data. We ensure that they are protected against unauthorised access and unauthorised changes or loss. Protecting IT systems is key to a peaceful and inclusive society as well as strong institutions.


Data protection

Protecting patients and customer data is a top priority for us. We respect and protect the personal data and privacy of patients when processing their data. Our Data Protection Policy contains general rules on the organisation and responsibilities of the Galenica Group with regard to data protection. Data protection is an important basis of a peaceful and inclusive society as well as strong institutions.


Reliable procurement and supply chain

We work closely with suppliers to ensure the greatest possible availability of medicines. An IT-based scheduling system also helps us to optimise procurement and logistics processes. Reliable provision of medicines to the population is key to promoting health and well-being.


Employee motivation and development

Our employees play a key role in our success. We consistently promote employee motivation and development by offering our employees attractive and fair employment conditions, modern and flexible working models and various programmes and opportunities for further development. We also support the next generation of qualified employees by training apprentices. Through all these measures, we are supporting sustainable labour and economic growth in Switzerland.


Retention of qualified employees

Retaining qualified employees in the healthcare professions and IT sectors is a major challenge in Switzerland. Our recruitment strategy includes measures to promote the company’s image as an employer, positioning and university marketing for pharmaceutical students in order to secure qualified employees. In doing so, we are supporting sustainable labour and economic growth in Switzerland.


Occupational health and safety

The physical and mental health of employees is very important at Galenica. This is why we take all possible precautions to protect the health and safety of all employees in the workplace. We also operate preventive case management in order to identify potential health risks at an early stage and ensure a quick return to work after an illness or accident. We are thus making a significant contribution to the health and well-being of our employees.


Diversity and equal opportunity

We are committed to diversity and equality and bring together people from 89 countries and all age groups. Three-quarters of employees are women. Our Code of Conduct states that we do not tolerate any discrimination or harassment. We also ensure that salaries are equal between men and women. We ensure equal opportunities and are committed to reducing inequalities. In doing this, we also contribute to SDG 5 (Gender Equality).


Corporate Governance

Good and transparent corporate governance is crucial for us to manage the company effectively and efficiently. In addition, corporate governance forms the basis for a peaceful and inclusive society based on equal participation of all people, as well as strong institutions.



We attach great importance to conducting our business activities ethical and legal manner. All of our business activities are conducted in accordance with applicable laws, and respect for human rights is nonnegotiable for us. This is how we contribute to a peaceful and inclusive society.

Galenica uses cookies to optimise the functions of the website and to ensure you enjoy the best possible experience. Use of cookies & disclaimer